Celularity CELU
NASDAQ CELU
$1.05 +0.03 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Celularity (CELU) Notes Payables (2021 - 2026)

Updated

Analysis

Celularity (CELU) Notes Payables (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Celularity 30.75 Mn 23.50 Mn 3.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.11 Mn
Mar 31, 2026 4.61 Mn
Dec 31, 2025 9.56 Mn
Sep 30, 2025 4.28 Mn
Jun 30, 2025 4.30 Mn
Mar 31, 2025 4.16 Mn
Dec 31, 2024 2.49 Mn
Dec 31, 2023 17.22 Mn
Sep 30, 2023 14.01 Mn
Jun 30, 2023 16.82 Mn
Mar 31, 2023 30.95 Mn
Dec 31, 2022 37.60 Mn
Sep 30, 2022 39.26 Mn
Jun 30, 2021 1.11 Mn
Mar 31, 2021 120,000.00
API Access

Celularity Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=CELU&period=max&api_key=YOUR_API_KEY